Updated February 17, 2023
Go to JCI Insight's conflict-of-interest policy
Almirall (J.E. Gudjonsson)
Arcus Biosciences (Y.M. Shah)
Arrowhead (A.P. Lieberman)
Arvinas (A.P. Lieberman)
BMS (J.E. Gudjonsson)
CStone (W. Zou)
Eli Lilly (J.E. Gudjonsson)
Galderma (J.E. Gudjonsson)
Intergalactic (W. Zou)
Janssen (J.E. Gudjonsson)
Johnson & Johnson (D. Martin)
Kyowa Kirin (J.E. Gudjonsson)
NextCure (W. Zou)
NGM Bio (W. Zou)
ONL Therapeutics (A. Tai)
Opsidio LLC (N. W. Lukacs)
Pfizer (D. Martin)
Prometheus (J.E. Gudjonsson)
Roivant (W. Zou)
